http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H0315397-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6de318c2c4a6de2fb41cb4406ac198d6 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-91 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P33-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-256 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-252 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7028 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-704 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7034 |
| filingDate | 1989-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_53b9a94e1b8b4fa898ac66ae3a54cfd2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a8db2b58c6d064b5d632ef8c8d17040c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a02fd07f494d0c1c7b48ecef4933112d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1facd93f9a7327819a9c389cb34faa09 |
| publicationDate | 1991-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-H0315397-A |
| titleOfInvention | Production of glucosyl glycyrrhetinate and anti-inflammatory agent |
| abstract | PURPOSE: To enable advantageous production of β-D-glucosyl glycyrrhetinate and utilization thereof by culturing a cell of a plant belonging to the genus Eucalyptus in a culture medium containing glycyrrhetinic acid or a salt thereof. n CONSTITUTION: A section of young tissues of a plant belonging to the genus Eucalyptus, such as Eucalyptus perrioina, is taken from a part, such as stem or leaf, sterilized, then cut into a suitable size and planted to a culture medium prepared by adding a carbon source, such as sucrose, and a phytohormone, such as auxin, to a Murashige-Skoog culture medium, etc., to induce calli. The resultant calli are subsequently inoculated into a liquid culture medium and subjected to shaking culture. After the number of the cells attains the maximum, a solution of glycyrrhetinic acid or salt thereof in ethanol is added to subsequently continue the culture. The obtained culture solution is then separated and purified to isolate β-D-glucosyl glycyrrhetinate expected to be extensively utilized as an anti-inflammatory agent in the form of a skin liniment or oral administration agent. n COPYRIGHT: (C)1991,JPO&Japio |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111718888-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111718888-B |
| priorityDate | 1989-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 40.